Gross Margin

Ethical food leader Vital Farms heads to the ICR Conference with record profits and a $2B goal, ready to prove its model can win against new competition.

Fresh off a volatile IPO, Malaysian hotpot chain CCH Holdings plans a massive 2026 expansion. Can this small-cap company conquer the U.S. and Africa?

iQSTEL caps a transformational year with a NASDAQ uplist, record revenue, and a strategic pivot to Fintech and Cybersecurity, eyeing a $1B future.

DHT Holdings sells two older tankers for $101.6M, securing a major cash injection. The move highlights a strategy of fleet renewal and shareholder value.

Indonesia's Mowilex marks seven years of verified carbon neutrality, pivoting from certificates to permanent infrastructure with major solar power investments.

With a strong debut on the Hong Kong Stock Exchange, USAS Building System highlights growing investor faith in prefabricated industrial construction.

Biomaterials firm Bolt Projects posts huge revenue gains and raises 2026 guidance, but a looming Nasdaq delisting threat casts a shadow on its future.

The cardiac device innovator adds seasoned sales and operations executives to prepare its novel cryoablation technology for the global market.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

Chinese insurtech Huize is cutting back on financial reports to focus on strategy, but its latest data shows a complex picture of soaring premiums and slowing new user growth.

Medical cannabis firm Crucial Innovations retains FOCUS Capital Partners, signaling a push for institutional investment and a potential 2026 US listing.

The 2025 Governors' Awards reveal how historic sites are being transformed into hubs for social housing, Reconciliation, and economic growth across Canada.

A new report projects a staggering $47T cost from chronic illness by 2039. Experts say prevention and innovation could save trillions and 13.5M lives.

RPM's strategic acquisition of Dealers Choice Auto Transport signals a major shift, combining enterprise logistics tech with white-glove specialty service.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

Struggling Inno Holdings rolls the dice with a massive reverse stock split to avoid delisting, but grim financials and a brutal market reaction raise alarms.

A new study reveals Gen X faces a shocking $400K retirement shortfall, caught between fading pensions and an imperfect 401(k) system. Are they prepared?

SCALE AI's record funding fuels 44 new projects, aiming to accelerate homegrown AI and secure Canada's digital future amid fierce global competition.

Beijing touts its Sanjiangyuan project as a win for ecology and herders. But beyond the state narrative lies a complex story of coercion and cultural risk.